Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05722340

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

Led by University Hospital, Montpellier · Updated on 2026-04-02

24

Participants Needed

1

Research Sites

182 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Montpellier

Lead Sponsor

G

Grace Asso (Groupe francophone de Réhabilitation Améliorée après Chirurgie)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main objective of this study is to compare two independent groups of patients requiring lung biopsy for undetermined interstitial lung disease (ILD) in terms of diagnostic confidence as determined by histologists.

CONDITIONS

Official Title

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with purported interstitial lung disease
  • Patient requiring a surgical lung biopsy to reinforce diagnosis according to current recommendations and validated by a multidisciplinary assessment
  • Minimum age: 18 years
Not Eligible

You will not qualify if you...

  • Contra-indication for surgery
  • Uncontrolled oesophageal gastric reflux despite optimal treatment
  • Thoracic deformation (e.g., pectus excavatum/carinatum or major scoliosis)
  • Risk of pleural adhesion (e.g., previous thoracic surgery)
  • History of abnormal bleeding
  • Predictable risk of difficult intubation
  • Body mass index (BMI) > 30
  • Severe cardiovascular comorbidity (e.g., unstable ischemic cardiomyopathy)
  • Unable to comply with all trial procedures/visits (e.g., language barriers, upcoming move, unwillingness to follow-up)
  • Protected populations as per French Public Health Code (e.g., pregnant, lactating women, prisoners, adults under guardianship)
  • Participation in another interventional study within the past month or exclusion period
  • Non-beneficiary of the French national medical insurance system
  • Lack of signed informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Département d'Anesthésie et Réanimation Cardiothoracique - CHU Arnaud de Villeneuve

Montpellier, France

Actively Recruiting

Loading map...

Research Team

T

Timothée JOUITTEAU, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here